Atlas Trials

Combo of Abraxane, TMZ, Bevacizumab in Metastatic Melanoma With Brain Metastases

Clinical trial NCT02065466 · WITHDRAWN

Trial details

NCT number
NCT02065466
Sponsor
University of Arizona
Status
WITHDRAWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Metastatic MelanomaBrain Metastases
Start date
2014-07-01
Primary completion
2015-02-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.